Cite
A REGULATORY PERSPECTIVE OF 505 (b) (2) NEW DRUG APPLICATION.
MLA
Nagaraju, P., et al. “A REGULATORY PERSPECTIVE OF 505 (b) (2) NEW DRUG APPLICATION.” International Journal of Pharmaceutical, Chemical & Biological Sciences, vol. 5, no. 1, Jan. 2015, pp. 129–37. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=115922542&authtype=sso&custid=ns315887.
APA
Nagaraju, P., Gowthami, K., Lakshmi, T., Nagabhushanam, M. V., & Reddy, D. N. (2015). A REGULATORY PERSPECTIVE OF 505 (b) (2) NEW DRUG APPLICATION. International Journal of Pharmaceutical, Chemical & Biological Sciences, 5(1), 129–137.
Chicago
Nagaraju, P., K. Gowthami, T. Lakshmi, M. V. Nagabhushanam, and D. Nagarjuna Reddy. 2015. “A REGULATORY PERSPECTIVE OF 505 (b) (2) NEW DRUG APPLICATION.” International Journal of Pharmaceutical, Chemical & Biological Sciences 5 (1): 129–37. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=115922542&authtype=sso&custid=ns315887.